Hemodilution reduces clinic and ambulatory blood pressure in polycythemic patients

Hypertension

Volumn 31, Issue 3, 1998, Pages 848-853

  Bertinieri, Giovanni ^d   Parati, Gianfranco ^b   Ulian, Luisa ^d   Santucciu, Cinzia ^d   Massaro, Paolo ^d   Cosentini, Roberto ^d   Torgano, Giuseppe ^d   Morganti, Alberto ^d   Mancia, Giuseppe ^a,c  

^a SAN GERARDO HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NONE

Author keywords

Blood pressure monitoring, ambulatory; Blood viscosity; Hemodilution; Hemorheology

Indexed keywords

ENDOTHELIN 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD RHEOLOGY; BLOOD VISCOSITY; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MALE; POLYCYTHEMIA; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0031887676     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.848     Document Type: Article

References (53)

1. Fahraeus R, Lindqvist T. The viscosity of the blood in narrow capillary tubes. Am J Physiol. 1931;96:562-568.
2. Lipowsky HH, Usami S, Chien S. In vivo measurements of 'apparent viscosity' and microvessel hematocrit in the mesentery of cat. Microvasc Res. 1980;19:297-319.
3. Susic D, Mandai AK, Kentera D. Hemodynamic effects of chronic alterations in hematocrit in spontaneously hypertensive rats. Hypertension. 1984; 6:262-266.
4. De Clerck F, Beerens M, Van Gorp L, Zhonneux R. Blood hyperviscosity in spontaneously hypertensive rats. Thromb Res. 1980;18:791-795.
5. Seiffge P. Hemodilution in spontaneously hypertensive rats: its effect on blood pressure and blood rheology. Bibl Haematol. 1981;47:70-76.
6. Smith CWS, Lowe GDO, Lee AJ, Tunstall-Pedoe H. Rheological determinants of blood pressure in a Scottish adult population. J Hypertens. 1992;10:467-472.
7. Lowe GDO, Smith CWS, Tunstall-Pedoe H, Crombie IK, Lennie SE, Anderson J. Cardiovascular risk and haemorheology: results from the Scottish Heart Study and the Monica Project, Glasgow. Clin Hemorheol. 1988;8:517-524.
8. Fowkes FGR, Lowe GDO, Rumley A, Lennie SE, Smith FB, Donnan PT. The relationship between blood viscosity and the blood pressure in a random sample of the population age 55 to 74 years. Ear Heart J. 1993;14: 597-601.
9. Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and its concentration. Am J Med. 1981;70:1195-1202.
10. Palmer A, Stokes GS. Relationship between blood pressure and blood viscosity in men and women visiting a health screening clinic. In: Garlick D, ed. Festschrift for FC Courtice. Sidney, Australia: University of New South Wales; 1981.
11. Linde T, Sandhagen B, Hagg A, Morlin C, Wikstrom B, Danielson BG. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens. 1993;11:731-736.
12. Koenig W, Sund M, Ernst E, Keil U, Rosenthal J, Hombach V. Association between plasma viscosity and blood pressure. Am J Hypertens. 1991;4:529-536.
13. Letcher RL, Chien S, Pickering TG, Laragh JH. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension. 1983;5: 757-762.
14. Reid HL, Dsogwu LI. Hyperfibrinogenemia and hyperviscous plasma in hypertensive Africans. Angiology. 1992;43:826-832.
15. Cirillo M, Laurenzi M, Trevisan M. Hematocrit, blood pressure and hypertension: the Gubbio population study. Hypertension. 1992;20: 319-326.
16. Gaisbock F. Polycythaemia hypertonica. Deutsch Arch Klin Med. 1905; 83:396.
17. Emery AC, Whitcomb W, Frohlich D. 'Stress' polycythemia and hypertension. JAMA. 1974;229:159-162.
18. Zimmerman RS, Maymind M, Barbee RW. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension. 1994;23:205-210.
19. Morganti A, Giussani M, Sala C, Gazzano G, Marana I, Pierini A, Savoia MT, Ghio F, Cogo A, Zanchetti A. Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects. J Hypertens. 1995;13: 859-865.
20. Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun. 1990;170:649-656.
21. Cernacek P, Stewart J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun. 1989;161:562-567.
22. Shichiri M, Hirata Y, Ando K, Kanno K, Emory T, Ohta K. Postural change and volume expansion affect plasma endothelin levels. JAMA. 1990;263:661.
23. Chien S. Present state of blood rheology. In: Messmer K, Schmid-Schonbein H, eds. Hemodilution: Theoretical Basis and Clinical Application. Basel, Switzerland: Karger; 1972:1-40.
24. Chien S. Blood rheology in hypertension and cardiovascular disease. Cardiovasc Med. 1977;2:356-360.
25. Folkow B, Neil E. The viscosity factors. In: Folkow B, Neil E, eds. Circulation. New York, NY: Oxford University Press; 1971:24-35.
26. Harkness J. The viscosity of human blood plasma: its measurement in health and disease. Biorheology. 1971;8:171-193.
27. Chien S, Usami S, Dellenback RJ, Bryant CA. Blood viscosity: influence of erythrocyte deformation. Science. 1967;157:827-829.
28. Laragh SH, Sealey SE. The renin-angiotensin-aldosterone humoral system and regulation of sodium, potassium and blood pressure homeostasis. In: Orloff S, Berliner RW, eds. Handbook of Physiology: Renal Physiology. Bethesda, Md: American Physiological Society; 1973:831-908.
29. Joyner CR, Reid JM. Application of ultrasound in cardiology and cardiovascular physiology. Progr Cardiovasc Dis. 1963;2:352-371.
30. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension. 1992;20:227-232.
31. Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G, eds. Handbook of Hypertension, Vol. 17: Pathophysiology of Hypertension. Amsterdam, Netherlands: Elsevier; 1997: 117-169.
32. Chien S. Blood rheology in hypertension and cardiovascular diseases. Cardiovasc Med. 1977;2:356-360.
33. Petralito A, Malatino LS, Fione CE. Erythrocite aggregation in different stages of arterial hypertension. Thromb Haemost. 1985;54:555.
34. Dintenfass L, Girolami A. Rigidity of red cells in essential hypertension. Haemostasis. 1978;7:298-302.
35. Chabanel A, Chien S. Blood viscosity as a factor in human hypertension. In: JH Laragh, BM Brenner, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1990:329-337.
36. Fowler NO, Holmes JC. Blood viscosity and cardiac output in acute experimental anemia. J Appl Physiol 1975;39:3:453-456.
37. Chabanel A, Chien S. Blood viscosity as a factor in human hypertension. In Laragh-Brenner, ed. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1995:365-376.
38. Mancia G, Mark AL. Arterial baroreflexes in humans. In: Shepherd JT, Abboud FM, eds, Handbook of Physiology, Section 2: The Cardiovascular System, IV, Vol 3, Peripheral Circulation and Organ Blood Flow, Part 2. Bethesda, Md: American Physiological Society; 1983:755-794.
39. Reisin E, Abel R, Modan M. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978;298:1-6.
40. Morgan T, Adams W, Gellies A, Wilson M, Morgan G, Carney S. Hypertension treated by salt restriction. Lancet. 1978;1:227-230.
41. Silman AS, Locke C, Mitchell P, Humpherson P. Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension. Lancet. 1983;1:1179-1182.
42. Nelson L, Sennings GL, Esler MD, Korner PI. The effect of changing levels of physical activity on blood pressure and haemodynamics in patients with essential hypertension. Lancet. 1986;2:473-476.
43. Helgelan A. Treatment of mild hypertension: a 5-year controlled drug trial: the Oslo study. Am J Med. 1980;69:725-732.
44. Medical Research Council Working Party. MRC trial of treatment of hypertension: principal results. BMJ. 1985;291:97-104.
45. Niutta E, Cusi D, Colombo R. Antihypertensive effects of captopril, canrenoate potassium and atenolol: relation with red cell sodium transport and renin. Am J Hypertens. 1988;1:354-367.
46. Mancia G, Parati G, Pomidossi G, Grassi G, Bertinieri G, Buccino N, Ferrari A, Gregorini L, Rupoli L, Zanchetti A. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol. 1988;49: 1415-1419.
47. Mancia G, Parati G, Grassi G, Pomidossi G, Giannattasio C, Casadei R, Groppelli A, Saino A, Gregorini L, Perondi R, Zanchetti A. Calcium antagonists and neural control of circulation in essential hypertension. J Hypertens. 1984;5(suppl 4):S49-S55.
48. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens. 1991;9: 361-364.
49. Dupont AG, Van der Niepen P, Six RU. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol. 1987;24:106-109.
50. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G. Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens. 1991;9: 115-119.
51. Gould BA, Mann S, Davies AB, Altman B, Raftery EB. Does placebo lower blood pressure? Lancet 1981;2:1377-1381.
52. Guyton AC, Taylor AE, Granger HJ. Circulatory Physiology: II. Dynamics and Control of Body Fluids. Philadelphia, Pa: WB Saunders; 1975.
53. Leschke M, Motz W, Blanke H, Strauer BE. Blood rheology in hypertension and hypertensive heart disease. J Cardiovasc Pharmacol. 1987; 10(suppl 6):S103-S110.